Virus News and Research

Latest Virus News and Research

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

While global incidence rates of HIV have declined notably in recent years, the virus that causes AIDS remains a major and, in some ways largely unmitigated, public health threat in some countries and regions.

17 Aug 2018

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

17 Aug 2018

Researchers develop new approach to study how tuberculosis infects people

Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected.

17 Aug 2018

Transgenic rice plant extracts could help stop the spread of HIV

Extracts from transgenic rice plants could help stop the spread of HIV, according to research results from an international effort that included an Iowa State University scientist.

17 Aug 2018

Discovery may help broaden the scope of defenses against HPV

Yale Cancer Center scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus infects cells.

16 Aug 2018

Researchers use super-resolution microscope to unravel secrets of deadly Nipah virus

The deadly Nipah virus and others like it assemble themselves in a much more haphazard manner than previously thought, new UBC research has found. The discovery could allow scientists to develop more effective vaccines and rule out many approaches to fighting these viruses.

16 Aug 2018

NIH begins first-in-human trial of experimental live, attenuated Zika virus vaccine

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

16 Aug 2018

New HIV therapy suppresses viral replication and increases immune cells in drug-resistant patients

In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.

16 Aug 2018

Study uncovers mechanism that affects multiplication of dengue virus lineage

A lineage of type 1 dengue virus found in Brazil is able to prevail over another even though it multiplies less in vector mosquitoes and infected human cells.

15 Aug 2018

New polyclonal immunotherapy successfully neutralizes Ebola virus

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.

15 Aug 2018

Ebola outbreak in Congo spreads to active combat zone

The outbreak of the deadly Ebola in the Democratic Republic of Congo has spread outside the province of North Kivu according to a statement made by the country’s health ministry yesterday. With this the viral infection has reached an active conflict zone and this may mean that it could spread wider now.

14 Aug 2018

Simple intervention during routine care reduces alcohol consumption in men with HIV

Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder.

14 Aug 2018

Study: IgG3 antibody stops B cells from fighting pathogens in HIV patients

For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 stops the immune system's B cells from doing their normal job of fighting pathogens.

14 Aug 2018

Researchers find link between common 'harmless' virus and cardiovascular damage

Researchers from Brighton and Sussex Medical School have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

13 Aug 2018

Advances in treating hep C lead to new option for transplant patients

After her kidneys failed from the same illness that took the lives of her mother and brother, Anne Rupp went on dialysis in May 2016, spending three hours a day, three times a week undergoing the blood-cleaning procedure. She hated it.

13 Aug 2018

Experts highlight key knowledge gaps that need to be addressed in Ebola vaccine research

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium.

13 Aug 2018

Genetic sequencing method identifies pathogens behind respiratory illnesses in Uganda

A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.

10 Aug 2018

Supercomputer simulations reveal potential therapeutic target in HIV-1 replication

HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies.

10 Aug 2018

Scientists make surprising discovery in nerve cells

Purkinje cells are a central part of the human cerebellum, the part of the brain that plays an important role in motor learning, fine motor control of the muscle, equilibrium and posture but also influences emotions, perception, memory and language.

10 Aug 2018

FIND and genedrive announce study agreement to evaluate HCV ID Kit

genedrive plc, a near patient molecular diagnostics company, and the Foundation for Innovation of New Diagnostics (FIND), announced today a study agreement for the performance evaluation of genedrive plc’s hepatitis C virus (HCV) Genedrive HCV ID Kit.

10 Aug 2018

Virus News and Research

Latest Virus News and Research

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Researchers develop new approach to study how tuberculosis infects people

Transgenic rice plant extracts could help stop the spread of HIV

Discovery may help broaden the scope of defenses against HPV

Researchers use super-resolution microscope to unravel secrets of deadly Nipah virus

NIH begins first-in-human trial of experimental live, attenuated Zika virus vaccine

New HIV therapy suppresses viral replication and increases immune cells in drug-resistant patients

Study uncovers mechanism that affects multiplication of dengue virus lineage

New polyclonal immunotherapy successfully neutralizes Ebola virus

Ebola outbreak in Congo spreads to active combat zone

Simple intervention during routine care reduces alcohol consumption in men with HIV

Study: IgG3 antibody stops B cells from fighting pathogens in HIV patients

Researchers find link between common 'harmless' virus and cardiovascular damage

Advances in treating hep C lead to new option for transplant patients

Experts highlight key knowledge gaps that need to be addressed in Ebola vaccine research

Genetic sequencing method identifies pathogens behind respiratory illnesses in Uganda

Supercomputer simulations reveal potential therapeutic target in HIV-1 replication

Scientists make surprising discovery in nerve cells

FIND and genedrive announce study agreement to evaluate HCV ID Kit

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in